Method for treating viral diseases with attenuated virus
AssigneeUnited Cancer Research Institute
InventorsLaszlo K. Csatary, Richard J. Massey
Life of this patent
Estimating the term…
Abstract
A method for treating human disease of viral etiology which employs the administration of a pharmaceutically effective amount of a live attenuated virus. Avian paramyxovirus is the virus preferred for use in live attenuated vaccine form, although other viruses of human and nonhuman origin have also been shown to be effective. The administration of a pharmaceutically effective amount of avian paramyxovirus and avian rotavirus vaccine has been shown to be efficacious in the treatment of Herpes virus infections, hepatitis, some cancers, aphthous stomatitis, acquired immune deficiency syndrome (AIDS) and polyarteritis nodosa.
Claims5
A method of treating human patients infected with acquired immune deficiency syndrome virus and characterized by a depletion in the number of T-4 helper-inducer T cells in an infected patient's immune system, said method comprising the administration to said infected patient of an amount of an attentuated avian paramyxovirus effective to increase the number of T-4 helper-inducer T cells in said infected patient.
A method of treating human patients infected with acquired immune deficiency syndrome virus comprising the administration to an infected patient of a pharmaceutically effective amount of an attenuated avian paramyxovirus.
Dependencies are inferred from the claim text.